You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Harvard Business School
Mallinckrodt
Johnson and Johnson
Express Scripts
Medtronic
McKinsey

Last Updated: September 29, 2020

DrugPatentWatch Database Preview

Details for Patent: 8,053,448

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which drugs does patent 8,053,448 protect, and when does it expire?

Patent 8,053,448 protects YUPELRI and is included in one NDA.

This patent has thirty-seven patent family members in twenty-seven countries.

Summary for Patent: 8,053,448
Title:Biphenyl compounds useful as muscarinic receptor antagonists
Abstract: This invention provides methods of using compounds of formula Ib below to treat pulmonary disorders. ##STR00001## wherein: R.sup.4 is hydrogen or (1-4C)alkyl; q is 0, 1, or 2; R.sup.5 is independently selected from halo, (1-4C)alkyl, and (1-4C)alkoxy, wherein each alkyl and alkoxy group is optionally substituted with from 1 to 3 fluoro substituents; R.sup.7 is hydrogen or (1-4C)alkyl; or a pharmaceuticallly acceptable salt thereof.
Inventor(s): Mammen; Mathai (Menlo Park, CA), Ji; YuHua (Redwood City, CA), Mu; YongQi (Los Altos, CA), Husfeld; Craig (Redwood City, CA), Li; Li (Sunnyvale, CA)
Assignee: Theravance, Inc. (South San Francisco, CA)
Application Number:13/024,532
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 8,053,448

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Mylan Ireland Ltd YUPELRI revefenacin SOLUTION;INHALATION 210598-001 Nov 9, 2018 RX Yes Yes   Start Trial   Start Trial FOR THE MAINTENANCE TREATMENT OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
AstraZeneca
Mallinckrodt
Dow
Moodys
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.